Rat models of experimental autoimmune encephalomyelitis

Source Book of Models for Biomedical Research

Volumn , Issue , 2008, Pages 547-556

  Wallström, Erik ^a   Olsson, Tomas ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antibodies; Astrocytes; Autoimmunity; Axons; B cells; Demyelination; Genetics; Inflammation; Macrophages; Major histocompatibility complex; Microglia; Multiple sclerosis; Myelin; Myelin basic protein; Myelin oligodendrocyte glycoprotein; Neurons; Oligodendrocytes; Proteolipid protein; T cells

Indexed keywords

EID: 84891459355     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59745-285-4_56     Document Type: Chapter

References (79)

1. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338(5):278-285.
2. Becker KG, Simon RM, Bailey-Wilson JE, et al. Clustering of nonmajor histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci USA 1998; 95(17):9979-9984.
3. Baron JL, Madri JA, Ruddle NH, Hashim G, Janeway CA Jr. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med 1993;177(1):57-68.
4. Dyment DA, Herrera BM, Cader MZ, et al. Complex interactions among MHC haplotypes in multiple sclerosis: Susceptibility and resistance. Hum Mol Genet 2005;14(14):2019-2026.
5. Fogdell-Hahn A, Ligers A, Gronning M, Hillert J, Olerup O. Multiple sclerosis: A modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens 2000;55(2): 140-148.
6. Saarela J, Kallio SP, Chen D, et al. PRKCA and multiple sclerosis: Association in two independent populations. PLoS Genet 2006;2(3): e42.
7. Zhang Z, Duvefelt K, Svensson F, et al. Two genes encoding immune-regulatory molecules (LAG3 and IL7R) confer susceptibility to multiple sclerosis. Genes Immun 2005;6(2):145-152.
8. A meta-analysis of genomic screens in multiple sclerosis. The Transatlantic Multiple Sclerosis Genetics Cooperative. Mult Scler 2001;7(1):3-11.
9. Vyshkina T, Shugart YY, Birnbaum G, Leist TP, Kalman B. Association of haplotypes in the beta-chemokine locus with multiple sclerosis. Eur J Hum Genet 2005;13(2):240-247.
10. Olsson T, Jagodic M, Piehl F, Wallström E. Genetics of autoimmune neuroinfl ammation. Curr Opin Immunol 2006;18(6):643-649.
11. Alvord EC Jr. The challenge: How good a model of MS is EAE today? Prog Clin Biol Res 1984;146:3-5.
12. Sriram S, Steiner I. Experimental allergic encephalomyelitis: A misleading model of multiple sclerosis. Ann Neurol 2005;58(6): 939-945.
13. Steinman L, Zamvil SS. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis. Trends Immunol 2005; 26(11):565-571.
14. Ransohoff RM. EAE: Pitfalls outweigh virtues of screening potential treatments for multiple sclerosis. Trends Immunol 2006;27(4):167-168.
15. Pettinelli CB, McFarlin DE. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: Requirement for Lyt 1+ 2-T lymphocytes. J Immunol 1981;127(4):1420-1423.
16. Ben-Nun A, Wekerle H, Cohen IR. The rapid isolation of clonable antigen-specifi c T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur J Immunol 1981;11(3):195-199.
17. Linington C, Bradl M, Lassmann H, Brunner C, Vass K. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/ oligodendrocyte glycoprotein. Am J Pathol 1988;130(3):443-454.
18. Katz-Levy Y, Neville KL, Girvin AM, et al. Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice. J Clin Invest 1999;104(5):599-610.
19. Gregersen JW, Holmes S, Fugger L. Humanized animal models for autoimmune diseases. Tissue Antigens 2004;63(5):383-394.
20. Bettelli E, Baeten D, Jager A, Sobel RA, Kuchroo VK. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J Clin Invest 2006;116(9):2393-2402.
21. Krishnamoorthy G, Lassmann H, Wekerle H, Holz A. Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation. J Clin Invest 2006; 116(9):2385-2392.
22. Willenborg DO. Experimental allergic encephalomyelitis in the Lewis rat: Studies on the mechanism of recovery from disease and acquired resistance to reinduction. J Immunol 1979;123(3):1145-1150.
23. Eng LF, Ghirnikar RS, Lee YL. Inflammation in EAE-role of chemokine/cytokine expression by resident and infiltrating cells. Neurochem Res 1996;21(4):511-525.
24. Weissert R, Wallstrom E, Storch MK, et al. MHC haplotypedependent regulation of MOG-induced EAE in rats. J Clin Invest 1998;102(6):1265-1273.
25. Storch MK, Stefferl A, Brehm U, et al. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol 1998;8(4):681-694.
26. Olsson T. Immunology of multiple sclerosis. Curr Opin Neurol Neurosurg 1992;5(2):195-202.
27. Steinman L. Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system. Cell 1996;85(3): 299-302.
28. Brehm U, Piddlesden SJ, Gardinier MV, Linington C. Epitope specifi city of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG). J Neuroimmunol 1999;97(1-2):9-15.
29. Ma C, Whiteley PE, Cameron PM, et al. Role of APC in the selection of immunodominant T cell epitopes. J Immunol 1999;163(12): 6413-6423.
30. Stepaniak JA, Gould KE, Sun D, Swanborg RH. A comparative study of experimental autoimmune encephalomyelitis in Lewis and DA rats. J Immunol 1995;155(5):2762-2769.
31. Weissert R, Svenningsson A, Lobell A, Degraaf KL, Andersson R, Olsson T. Molecular and genetic requirements for preferential recruitment of TCRBV8S2(+) T cells in Lewis rat experimental autoimmune encephalomyelitis. J Immunol 1998;160(2):681-690.
32. Berger T, Weerth S, Kojima K, Linington C, Wekerle H, Lassmann H. Experimental autoimmune encephalomyelitis: The antigen specifi city of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab Invest 1997;76(3): 355-364.
33. Kleinau S, Erlandsson H, Holmdahl R, Klareskog L. Adjuvant oils induce arthritis in the DA rat. I. Characterization of the disease and evidence for an immunological involvement. J Autoimmun 1991; 4(6):871-880.
34. Lorentzen JC, Glaser A, Jacobsson L, et al. Identifi cation of rat susceptibility loci for adjuvant-oil-induced arthritis. Proc Natl Acad Sci USA 1998;95(11):6383-6387.
35. Warren HS, Vogel FR, Chedid LA. Current status of immunological adjuvants. Annu Rev Immunol 1986;4:369-388.
36. Freund J. Some aspects of active immunization. Annu Rev Microbiol 1947;1:291-309.
37. Lavebratt C, Apt AS, Nikonenko BV, Schalling M, Schurr E. Severity of tuberculosis in mice is linked to distal chromosome 3 and proximal chromosome 9. J Infect Dis 1999;180(1):150-155.
38. Lorentzen JC, Issazadeh S, Storch M, et al. Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freunds adjuvant. J Neuroimmunol 1995;63(2):193-205.
39. Lenz DC, Wolf NA, Swanborg RH. Strain variation in autoimmunity: Attempted tolerization of DA rats results in the induction of experimental autoimmune encephalomyelitis. J Immunol 1999;163(4): 1763-1768.
40. Maatta JA, Eralinna JP, Roytta M, Salmi AA, Hinkkanen AE. Physical state of the neuroantigen in adjuvant emulsions determines encephalitogenic status in the BALB/c mouse. J Immunol Methods 1996;190(1):133-141.
41. Whitacre CC, Dowdell K, Griffin AC. Neuroendocrine influences on experimental autoimmune encephalomyelitis. Ann NY Acad Sci 1998;840:705-716.
42. Correa SG, Rodriguez-Galan MC, Rivero VE, Riera CM. Chronic varied stress modulates experimental autoimmune encephalomyelitis in Wistar rats. Brain Behav Immun 1998;12(2):134-148.
43. Mason D, MacPhee I, Antoni F. The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat. Immunology 1990;70(1):1-5.
44. Teuscher C, Bunn JY, Fillmore PD, Butterfield RJ, Zachary JF, Blankenhorn EP. Gender, age, and season at immunization uniquely infl uence the genetic control of susceptibility to histopathological lesions and clinical signs of experimental allergic encephalomyelitis: Implications for the genetics of multiple sclerosis. Am J Pathol 2004;165(5):1593-1602.
45. Teuscher C, Doerge RW, Fillmore PD, Blankenhorn EP. eae36, a locus on mouse chromosome 4, controls susceptibility to experimental allergic encephalomyelitis in older mice and mice immunized in the winter. Genetics 2006;172(2):1147-1153.
46. Cua DJ, Coffman RL, Stohlman SA. Exposure to T helper 2 cytokines in vivo before encounter with antigen selects for T helper subsets via alterations in antigen-presenting cell function. J Immunol 1996;157(7):2830-2836.
47. Trooster WJ, Teelken AW, Gerrits PO, et al. The effect of gonadectomy on the clinical course of chronic experimental allergic encephalomyelitis. Clin Neurol Neurosurg 1996;98(3):222-226.
48. Bebo BF, Schuster JC, Vandenbark AA, Offner H. Gender differences in experimental autoimmune encephalomyelitis develop during the induction of the immune response to encephalitogenic peptides. J Neurosci Res 1998;52(4):420-426.
49. Dahlman I, Wallstrom E, Weissert R, et al. Linkage analysis of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the rat identifies a locus controlling demyelination on chromosome 18. Hum Mol Genet 1999;8(12):2183-2190.
50. Wallstrom E, Weissert R, Lorentzen J, Olsson T. Major histocompatibility complex haplotype RT1(av1) is associated with relapsing/ remitting experimental autoimmune encephalomyelitis. Transplant Proc 1997;29(3):1686-1689.
51. Jansson L, Holmdahl R. Estrogen-mediated immunosuppression in autoimmune diseases. Infl amm Res 1998;47(7):290-301.
52. Butterfield RJ, Blankenhorn EP, Roper RJ, et al. Genetic analysis of disease subtypes and sexual dimorphisms in mouse experimental allergic encephalomyelitis (EAE): Relapsing/remitting and monophasic remitting/ nonrelapsing EAE are immunogenetically distinct. J Immunol 1999;162(5):3096- 3102.
53. Teuscher C, Noubade R, Spach K, et al. Evidence that the Y chromosome influences autoimmune disease in male and female mice. Proc Natl Acad Sci USA 2006;103(21):8024-8029.
54. Weinshenker BG, Bass B, Rice GP, et al. The natural history of multiple sclerosis: A geographically based study. I. Clinical course and disability. Brain 1989;112(Pt. 1):133-146.
55. Hedrich HJ. Genetic Monitoring of Inbred Strains of Rats. New York: Gustav Fischer Verlag, 1990.
56. Olofsson P, Johansson A, Wedekind D, et al. Inconsistent susceptibility to autoimmunity in inbred LEW rats is due to genetic crossbreeding involving segregation of the arthritis-regulating gene Ncf1. Genomics 2004;83(5):765-771.
57. Gould KE, Stepaniak JA, Swanborg RH. Variable susceptibility of Lewis rats to experimental autoimmune encephalomyelitis. J Neuroimmunol 1994;54(1-2):145-146.
58. Stefferl A, Brehm U, Storch M, et al. Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the "resistant" brown Norway rat: Disease susceptibility is determined by MHC and MHC-linked effects on the B cell response. J Immunol 1999;163(1):40-49.
59. Muhallab S, Dahlman I, Wallstrom E. Disparate MHC class II haplotypes in myelin oligodendrocyte glycoprotein-and myelin basic protein-induced experimental autoimmune encephalomyelitis. J Neuroimmunol 2005;161(1-2):155-161.
60. Williams RM, Moore MJ. Linkage of susceptibility to experimental allergic encephalomyelitis to the major histocompatibility locus in the rat. J Exp Med 1973;138(4):775-783.
61. Jersild C, Fog T, Hansen GS, Thomsen M, Svejgaard A, Dupont B. Histocompatibility determinants in multiple sclerosis, with special reference to clinical course. Lancet 1973;2(840):1221-1225.
62. Jersild C, Svejgaard A, Fog T. HL-A antigens and multiple sclerosis. Lancet 1972;1(762):1240-1241.
63. Barcellos LF, Sawcer S, Ramsay PP, et al. Heterogeneity at the HLADRB1 locus and risk for multiple sclerosis. Hum Mol Genet 2006;15(18):2813-2824.
64. Hurt P, Walter L, Sudbrak R, et al. The genomic sequence and comparative analysis of the rat major histocompatibility complex. Genome Res 2004;14(4):631-639.
65. Mustafa M, Vingsbo C, Olsson T, Issazadeh S, Ljungdahl A, Holmdahl R. Protective influences on experimental autoimmune encephalomyelitis by MHC class I and class II alleles. J Immunol 1994;153(7):3337-3344.
66. de Graaf KL, Berne GP, Herrmann MM, Hansson GK, Olsson T, Weissert R. CDR3 sequence preference of TCRBV8S2+ T cells within the CNS does not reflect single amino acid dependent avidity expansion. J Neuroimmunol 2005;166(1-2):47-54.
67. de Graaf KL, Weissert R, Kjellen P, Holmdahl R, Olsson T. Allelic variations in rat MHC class II binding of myelin basic protein peptides correlate with encephalitogenicity. Int Immunol 1999; 11(12):1981-1988.
68. Weissert R, de Graaf KL, Storch MK, et al. MHC class II-regulated central nervous system autoaggression and T cell responses in peripheral lymphoid tissues are dissociated in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J Immunol 2001;166(12):7588-7599.
69. Storch MK, Weissert R, Steffer A, et al. MHC gene related effects on microglia and macrophages in experimental autoimmune encephalomyelitis determine the extent of axonal injury. Brain Pathol 2002;12(3):287-299.
70. Dahlman I, Jacobsson L, Glaser A, et al. Genome-wide linkage analysis of chronic relapsing experimental autoimmune encephalomyelitis in the rat identifies a major susceptibility locus on chromosome 9. J Immunol 1999;162(5):2581-2588.
71. Jagodic M, Becanovic K, Sheng JR, et al. An advanced intercross line resolves Eae18 into two narrow quantitative trait loci syntenic to multiple sclerosis candidate loci. J Immunol 2004;173(2):1366-1373.
72. Jagodic M, Marta M, Becanovic K, et al. Resolution of a 16.8-Mb autoimmunity-regulating rat chromosome 4 region into multiple encephalomyelitis quantitative trait loci and evidence for epistasis. J Immunol 2005;174(2):918-924.
73. Olofsson P, Holmberg J, Tordsson J, Lu S, Akerstrom B, Holmdahl R. Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. Nat Genet 2002;2:2.
74. Becanovic K, Jagodic M, Sheng JR, et al. Advanced intercross line mapping of Eae5 reveals Ncf-1 and CLDN4 as candidate genes for experimental autoimmune encephalomyelitis. J Immunol 2006;176(10):6055-6064.
75. Encinas JA, Wicker LS, Peterson LB, et al. QTL influencing autoimmune diabetes and encephalomyelitis map to a 0.15-cM region containing Il2. Nat Genet 1999;21(2):158-160.
76. Kjellen P, Issazadeh S, Olsson T, Holmdahl R. Genetic infl uence on disease course and cytokine response in relapsing experimental allergic encephalomyelitis. Int Immunol 1998;10(3):333-340.
77. Russell WMS, Burch RL. The Principles of Humane Experimental Techniques. London: Methuen, 1959.
78. Yamamura T, Namikawa T, Endoh M, Kunishita T, Tabira T. Experimental allergic encephalomyelitis induced by proteolipid apoprotein in Lewis rats. J Neuroimmunol 1986;12(2):143-153.
79. Issazadeh S, Kjellen P, Olsson T, Mustafa M, Holmdahl R. Major histocompatibility complex-controlled protective influences on experimental autoimmune encephalomyelitis are peptide specifi c. Eur J Immunol 1997;27(6):1584-1587.